Xilio Therapeutics (XLO) Cash flow

219 Followers

Xilio Therapeutics Cash Flow

XLO's free cash flow for Q4 2025 was $-2.09M. For the 2025 fiscal year, XLO's free cash flow was decreased by $12.90M and operating cash flow was $-2.00M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -4.99M	$ -18.38M	$ -68.62M	$ -75.72M	$ -80.75M
Investing Cash Flow	$ -518.00K	$ -36.00K	$ -486.00K	$ -1.87M	$ -1.10M
Financing Cash Flow	$ 87.78M	$ 29.20M	$ -6.55M	$ -69.00K	$ 260.67M
End Cash Position	$ 139.34M	$ 57.07M	$ 44.70M	$ 120.39M	$ 199.61M
Free Cash Flow	$ -5.51M	$ -18.41M	$ -69.11M	$ -77.59M	$ -81.85M

Currency in USD